ArticleIJID regions2025

Real-world effectiveness, safety, and health-related quality of life in people living with HIV receiving bictegravir/emtricitabine/tenofovir alafenamide-12-month results of the BICSTaR French cohort.

Laurent Hocqueloux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.